Baxalta Incorporated Common Sto (BXLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BXLT | AZN | AMGN | GILD | VRTX |
| Company | Baxalta Incorporated Common Sto | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 46.27 | 89.40 | 317.30 | 122.86 | 444.81 |
| High | 46.52 | 89.96 | 319.46 | 123.63 | 456.00 |
| Low | 46.01 | 89.28 | 315.19 | 119.53 | 444.81 |
| Latest | 46.02 | 89.83 | 317.74 | 120.40 | 452.04 |
| Change | -0.18 | -0.46 | +0.36 | -2.81 | +6.11 |
| % Change | -0.39% | -0.51% | +0.11% | -2.28% | +1.37% |
| Volume | 228,648,297 | 5,377,200 | 2,247,300 | 6,767,800 | 1,621,600 |
| 20-Day Average Volume | 24,994,385 | 5,691,210 | 2,860,580 | 7,054,955 | 1,390,000 |
| Previous Close | 46.20 | 90.29 | 317.38 | 123.21 | 445.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 43.79 | 90.60 | 334.04 | 124.22 | 437.64 |
| 20-Day Raw Stochastic | 91.45% | 27.03% | 15.75% | 16.37% | 73.94% |
| 20-Day Relative Strength | 68.35 | 55.38 | 47.77 | 47.25 | 59.32 |
| Weighted Alpha | +50.40 | +37.82 | +17.55 | +27.75 | +1.65 |
| Today's Opinion | N/A | 88% Buy | 72% Buy | 56% Buy | 40% Buy |
| Previous Opinion | N/A | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | N/A | 100% Buy | 56% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.70% since 05/26/16 | -0.39% since 12/05/25 | -3.68% since 12/05/25 | -0.68% since 12/05/25 | -0.76% since 12/05/25 |
| Low | 45.23 on 05/31/16 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 46.52 on 06/02/16 | 91.66 on 12/10/25 | 329.67 on 12/08/25 | 123.74 on 12/11/25 | 457.17 on 12/08/25 |
| 1-Month | |||||
| %Chg | +9.21% since 05/02/16 | +2.45% since 11/12/25 | -5.51% since 11/12/25 | -2.43% since 11/12/25 | +4.11% since 11/12/25 |
| Low | 40.67 on 05/06/16 | 87.62 on 11/13/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 46.52 on 06/02/16 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +15.34% since 03/02/16 | +12.91% since 09/12/25 | +14.96% since 09/12/25 | +5.11% since 09/12/25 | +14.58% since 09/12/25 |
| Low | 37.44 on 03/16/16 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 46.52 on 06/02/16 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +29.16% since 12/02/15 | +19.77% since 06/12/25 | +6.88% since 06/12/25 | +7.45% since 06/12/25 | -1.74% since 06/12/25 |
| Low | 34.50 on 12/04/15 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 46.52 on 06/02/16 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 31,579,550 | 278,601,088 | 171,096,960 | 149,377,888 | 114,691,136 |
| Shares Outstanding, K | 683,080 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 6,148,000,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 956,000,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 1,548,000,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 145,000,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | N/A | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.47 on 04/28/16 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 08/04/16 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | 0.070 on 03/08/16 | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | 06/08/16 | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 23.10 | 19.76 | 14.51 | 15.04 | 29.13 |